JP2022533030A5 - - Google Patents
Info
- Publication number
- JP2022533030A5 JP2022533030A5 JP2021564691A JP2021564691A JP2022533030A5 JP 2022533030 A5 JP2022533030 A5 JP 2022533030A5 JP 2021564691 A JP2021564691 A JP 2021564691A JP 2021564691 A JP2021564691 A JP 2021564691A JP 2022533030 A5 JP2022533030 A5 JP 2022533030A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- seq
- administration
- cgrp antibody
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025174054A JP2026016471A (ja) | 2019-05-02 | 2025-10-16 | 抗ｃｇｒｐ抗体を用いた頭痛の治療 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842162P | 2019-05-02 | 2019-05-02 | |
| US62/842,162 | 2019-05-02 | ||
| US201962872989P | 2019-07-11 | 2019-07-11 | |
| US62/872,989 | 2019-07-11 | ||
| USPCT/US2020/012781 | 2020-01-08 | ||
| PCT/US2020/012781 WO2020146527A1 (en) | 2019-01-08 | 2020-01-08 | Acute treatment and rapid treatment of headache using anti-cgrp antibodies |
| PCT/US2020/018702 WO2020222892A1 (en) | 2019-05-02 | 2020-02-18 | Treatment of headache using anti-cgrp antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025174054A Division JP2026016471A (ja) | 2019-05-02 | 2025-10-16 | 抗ｃｇｒｐ抗体を用いた頭痛の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533030A JP2022533030A (ja) | 2022-07-21 |
| JP2022533030A5 true JP2022533030A5 (https=) | 2023-02-06 |
Family
ID=73028680
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564691A Pending JP2022533030A (ja) | 2019-05-02 | 2020-02-18 | 抗ｃｇｒｐ抗体を用いた頭痛の治療 |
| JP2025174054A Pending JP2026016471A (ja) | 2019-05-02 | 2025-10-16 | 抗ｃｇｒｐ抗体を用いた頭痛の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025174054A Pending JP2026016471A (ja) | 2019-05-02 | 2025-10-16 | 抗ｃｇｒｐ抗体を用いた頭痛の治療 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220251178A1 (https=) |
| EP (1) | EP3962522A4 (https=) |
| JP (2) | JP2022533030A (https=) |
| KR (1) | KR20220004053A (https=) |
| CN (1) | CN113811326A (https=) |
| AU (1) | AU2020267107B2 (https=) |
| BR (1) | BR112020027063A2 (https=) |
| CA (1) | CA3133571A1 (https=) |
| CL (1) | CL2021002866A1 (https=) |
| DO (1) | DOP2021000215A (https=) |
| EA (1) | EA202192865A1 (https=) |
| GE (2) | GEP20257803B (https=) |
| IL (1) | IL287759A (https=) |
| JO (1) | JOP20210247A1 (https=) |
| MA (1) | MA55815A (https=) |
| MX (1) | MX2021013426A (https=) |
| PH (1) | PH12021552422A1 (https=) |
| SG (1) | SG11202110637RA (https=) |
| WO (1) | WO2020222892A1 (https=) |
| ZA (1) | ZA202106627B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL310885A (en) * | 2021-08-27 | 2024-04-01 | H Lundbeck As | Treatment of cluster headache using anti-CGRP antibodies |
| KR20240058082A (ko) | 2021-09-15 | 2024-05-03 | 하. 룬드벡 아크티에셀스카브 | 항-cgrp 항체 투약 및 스크리닝 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107827982B (zh) * | 2011-05-20 | 2021-07-06 | H.伦德贝克公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途 |
| PE20141787A1 (es) * | 2011-05-20 | 2014-12-07 | Alderbio Holdings Llc | Composiciones anti-cgrp y uso de las mismas |
| AU2015230933B2 (en) * | 2014-03-21 | 2020-08-13 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| TWI799849B (zh) * | 2015-04-24 | 2023-04-21 | 美商安美基公司 | 治療或預防偏頭痛之方法 |
| AR104847A1 (es) * | 2015-06-17 | 2017-08-16 | Lilly Co Eli | Formulación de anticuerpo anti-cgrp |
| EP3448427A1 (en) * | 2016-04-29 | 2019-03-06 | CureVac AG | Rna encoding an antibody |
| CN109952314A (zh) * | 2016-09-23 | 2019-06-28 | 泰瓦制药国际有限公司 | 治疗难治性偏头痛 |
| WO2020146527A1 (en) * | 2019-01-08 | 2020-07-16 | Alder Biopharmaceuticals, Inc. | Acute treatment and rapid treatment of headache using anti-cgrp antibodies |
-
2020
- 2020-02-18 KR KR1020217035290A patent/KR20220004053A/ko active Pending
- 2020-02-18 EP EP20798303.2A patent/EP3962522A4/en active Pending
- 2020-02-18 CN CN202080030955.5A patent/CN113811326A/zh active Pending
- 2020-02-18 MA MA055815A patent/MA55815A/fr unknown
- 2020-02-18 AU AU2020267107A patent/AU2020267107B2/en active Active
- 2020-02-18 CA CA3133571A patent/CA3133571A1/en active Pending
- 2020-02-18 JP JP2021564691A patent/JP2022533030A/ja active Pending
- 2020-02-18 EA EA202192865A patent/EA202192865A1/ru unknown
- 2020-02-18 MX MX2021013426A patent/MX2021013426A/es unknown
- 2020-02-18 BR BR112020027063A patent/BR112020027063A2/pt unknown
- 2020-02-18 PH PH1/2021/552422A patent/PH12021552422A1/en unknown
- 2020-02-18 US US17/608,220 patent/US20220251178A1/en active Pending
- 2020-02-18 GE GEAP202015803A patent/GEP20257803B/en unknown
- 2020-02-18 WO PCT/US2020/018702 patent/WO2020222892A1/en not_active Ceased
- 2020-02-18 GE GEAP202515803A patent/GEAP202515803A/en unknown
- 2020-02-18 SG SG11202110637RA patent/SG11202110637RA/en unknown
- 2020-02-18 JO JOP/2021/0247A patent/JOP20210247A1/ar unknown
-
2021
- 2021-09-08 ZA ZA2021/06627A patent/ZA202106627B/en unknown
- 2021-10-19 DO DO2021000215A patent/DOP2021000215A/es unknown
- 2021-10-29 CL CL2021002866A patent/CL2021002866A1/es unknown
- 2021-11-01 IL IL287759A patent/IL287759A/en unknown
-
2025
- 2025-10-16 JP JP2025174054A patent/JP2026016471A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516956A5 (https=) | ||
| KR100435611B1 (ko) | 에피나스틴을포함하는동통치료용약제학적조성물 | |
| AU2025271432A1 (en) | CGRP antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo | |
| JP2000508341A (ja) | 片頭痛の治療法及び薬効の強化組成物 | |
| JP2022516957A5 (https=) | ||
| US11744810B2 (en) | Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder | |
| US20170281534A1 (en) | Administration of intravenous ibuprofen | |
| EA002166B1 (ru) | Фармацевтическая композиция, содержащая трамадол - лекарственное средство для лечения мигрени | |
| JP2022533030A5 (https=) | ||
| SK138095A3 (en) | Transdermal therapeutic system for the administration of serotonin agonists | |
| JPS63135330A (ja) | 不安症治療剤 | |
| WO1994016689A1 (fr) | Composition officinale analgesique | |
| CA2576385C (en) | Novel formulation for l-tryptophane comprising carbidopa/benserazide | |
| CA2893836C (en) | A combination medicament comprising phenylephrine and paracetamol | |
| RU2021133433A (ru) | Лечение головной боли с использованием антител к cgrp | |
| EP3954374A1 (en) | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
| RU2823100C2 (ru) | Анальгетическая субстанция эндогенной природы, фармацевтическая композиция на ее основе и способы их применения | |
| EP2726078B1 (en) | Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity | |
| RU2083202C1 (ru) | Препарат для анальгезии | |
| US4742076A (en) | Etodolac for lowering rheumatoid factor | |
| CA2919586A1 (en) | A pharmaceutical composition, use of a pharmaceutical composition and method for treating the symptoms of excess alcohol consumption | |
| Cashman | Routes of administration | |
| US20250345324A1 (en) | Combination formulations of naloxone and atipamezole | |
| Byers | Critical illness analgesia. | |
| HK1260854A1 (en) | Administration of intravenous ibuprofen |